Results 251 to 260 of about 29,513 (309)

Extrahepatic Cancer Risk in Patients with Hepatitis C Virus Infection Treated with Direct-Acting Antivirals. [PDF]

Microorganisms
Tani J, Masaki T, Oura K, Tadokoro T, Morishita A, Kobara H.   +5 more
europepmc   +1 more source

Immunomodulatory Effect of Tilapia (Oreochromis niloticus) Scale Gelatin Peptides in RAW264.7 Macrophages and Caenorhabditis elegans

Food Safety and Health, EarlyView.
ABSTRACT Currently, small‐molecular‐weight collagen peptides are a research hotspot in functional factor development due to their high bioavailability and diverse bioactivities. In this study, gelatin was extracted from tilapia (Oreochromis niloticus) scales by hot water extraction, followed by pepsin hydrolysis and ultrafiltration to obtain the < 3 ...
Ya‐ru Liu, Xu Guo, Shu‐tao Sun, Rui‐rui Zhang, Chao Liu, Ning‐yang Li   +5 more
wiley   +1 more source

Impact of viral eradication by direct-acting antivirals on clinical outcomes after curative treatment for hepatitis C virus-associated hepatocellular carcinoma. [PDF]

Ther Adv Gastroenterol
Nagaoki Y, Yamaoka K, Fujii Y, Uchikawa S, Fujino H, Ono A, Murakami E, Kawaoka T, Miki D, Aikata H, Hayes CN, Tsuge M, Oka S.   +12 more
europepmc   +1 more source

Effectiveness and Safety of Direct-Acting Antivirals in the Treatment of Chronic Hepatitis C: A Real-life Study in Northeastern Brazil. [PDF]

Rev Soc Bras Med Trop
Hyppolito EB, Ramos AN, Teixeira LP, Bezerra AM, Mendes LA, Silva TL, Lima JMC, Arruda ÉAG, Guerra EJ, Tavares MMS, Lima CEP, Esmeraldo TM, Pessoa FSRP, Pierre AMM, Pereira KB, Araújo Filho AH, Linhares LMC, Ferreira AF, Pires Neto RDJ.   +18 more
europepmc   +1 more source

A Comprehensive Review of Antiviral Therapy for Hepatitis C: The Long Journey from Interferon to Pan-Genotypic Direct-Acting Antivirals (DAAs). [PDF]

Viruses
Di Marco L, Cannova S, Ferrigno E, Landro G, Nonni R, Mantia C, Cartabellotta F, Calvaruso V, Di Marco V.   +8 more
europepmc   +1 more source

Direct-Acting Antivirals in Hepatitis C Treatment for Renal Impairment: Liver Safety Concerns and Effectiveness in Peritoneal Dialysis. [PDF]

Biomedicines
Hung HY, Hung WL, Gu Y, Chen CY.
europepmc   +1 more source

Outcomes of Direct-Acting Antivirals Versus Interferon-Based Therapy in Chronic Hepatitis C Infection.

Cureus
Chowdhury R, Rashid W, Singh T, Rehman A, Daterdiwala NF, Mkosi V, Limbu B, Bukhari SA, Ramadhan A, Dabas MM, Shehryar A, Khan R.   +11 more
europepmc   +1 more source

Sustained Virological Response as a Surrogate Marker for Mortality, Decompensated Cirrhosis, or Hepatocellular Carcinoma in People With Chronic Hepatitis C Virus Infection Treated With Direct-Acting Antivirals: Protocol for a Bayesian and Causal Mediation Analysis.

JMIR Res Protoc
Gurusamy KS, Gluud C.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Antiviral resistance and direct-acting antiviral agents for HCV

Antiviral Therapy, 2012
Direct-acting antiviral (DAA) agents specifically target viral proteins. Two DAAs have been already been approved for the treatment of HCV infection and many more are in development. DAA treatment of HCV infection, however, leads to the selection of viral variants (produced by the error-prone HCV polymerase) that are resistant to the DAA agent in use ...
Aloia, A., Locarnini, S., Beard, M.
openaire   +3 more sources